Armand Keating

Q Therapeutic Products, Inc. develops novel products to treat debilitating and fatal diseases. The company was founded by Dennis B. Farrar and Mahendra S. Rao in 2004 and is headquartered in Salt Lake, UT.

Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT.

NoNO, Inc. operates as a biotherapeutics company. It engages in the research, development, and commercialization of pharmaceuticals for the treatment of common health disorders that include strokes, traumatic brain injuries, and pains. The company was founded by Michael Tymianski and Michael W. Salter in 2003 and is headquartered in Toronto, Canada.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.

US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD.

The National Centre for Biological Sciences (NCBS) is a research institute located in Bangalore, IN. The Tata Institute for Genetics and Society (TIGS) is a non-profit research institute that aspires to develop solutions to challenges in human health and agriculture using applications of cutting-edge science and technology in genetics and genomics. The NCBS conducts research on various topics such as the assembly of mixed and branched heterotypic ubiquitin chains, evolution, and dopamine-neuropeptide axis maintenance in Drosophila. The institute has also been involved in tracking COVID and dengue through sewage surveillance. The institute is part of the Tata Institute of Fundamental Research and is dedicated to the study of stem cell and regenerative biology. The center for cellular and molecular platforms (C-CAMP) is an initiative of the Department of Biotechnology, Ministry of Science and Technology, with a mandate to be an enabler of cutting-edge life science research and innovation.

Nova, Inc. offers a digital media distribution platform which provides content delivery on mobile devices. It develops HTML5-based solution to distribute media content in a multi-platform environment, including smart phones, tablets and desktops. The company was founded by Michael Russo, Kunal Gupta, Rahul Agarwal, Gaurav Jain and Pratik Rathod in 2007 and is headquartered in Toronto, Canada.

Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada.

Pluristyx, Inc. is a privately held biotechnology company that helps industry and academic researchers solve manufacturing and analytical challenges in cryopreservation, drug development, regenerative medicine, and cell and gene therapy. The company is based in Seattle, WA and has subsidiaries in United States and Canada. The company has decades of experience supporting every stage of cell therapy product development, from cell banking to drug product manufacturing including analytical testing and release of clinical grade cell therapy products. Pluristyx offers consulting, wet-lab services, and pluripotent stem cell products to support novel therapeutic developers. The company was founded in 2018 by Kaye Reiter, Benjamin Fryer, Jason Carstens. Benjamin Fryer has been the CEO since 2018.

Part of Pluristyx, Inc., Implant Therapeutics is a Canadian biotechnology company that develops therapeutic products in the immunology, mesenchymal stem cell, and pancreatic islet space. The company partners with other companies to develop novel products in other areas of regenerative medicine. Under the guidance of Dr. Mahendra Rao, Implant Therapeutics engineers hypoimmunogenic and safe-harbor technologies in ipsc-msc and islets. These cells are an ideal choice for bone, cartilage, and tendon replacement strategies, combining the advantages of allogeneic and autologous cells, as well as allowing them to be used as ex-vivo gene therapy vehicles. The CEO of the company is Mahendra S. Rao.